Active Pharmaceutical Ingredient (API) Removal from Industrial Water Streams | Inopsys

 

Our proven approach to the removal of Active Pharmaceutical Ingredients (APIs) from side streams

 

Actively preventing pharmaceutical compounds from entering the environment (Pharmaceuticals in the Environment, PIE) within water streams and water treatment contexts.

Modern medicine has significantly improved global health: people live longer, recover faster and can manage diseases that were once fatal. For this progress, we can be genuinely grateful.
However, the growth of the pharmaceutical industry has also introduced an unintended challenge: Pharmaceuticals in the Environment (PIE). The release of pharmaceutical compounds into the environment poses a threat to both natural ecosystems and human health, as well as to water quality.

Active Pharmaceutical Ingredients (APIs) enter the environment primarily through three pathways, as shown on the figure:

  • Manufacturing
  • Usage
  • Disposal

Of these, manufacturing contributes the least, while usage and disposal account for the majority of API release into water streams. 

Under current EU regulations, the pollution caused by end-users is addressed through the polluter pays principle. At the same time, manufacturing and formulation sites are also obligated to minimize PIE. During API production and formulation, wash water often contain API traces that end up in wastewater and water treatment systems. Today, most of this wastewater is managed through incineration – an energy-intensive, expensive, and unsustainable solution.

 

  

 

Our solutions. 

Our technology trains can treat APIs at different stages of the production process and within the water treatment process. For example, we have developed a tailor-made solution for the early removal of steroids in the production chain, specifically designed to safely and effectively address the high potency of these APIs in industrial water streams.

For other scenarios, we have developed standardized solutions, such as combinations designed to remove a broad spectrum of pharmaceuticals effectively.

This standardized combination approach is based on our hybrid sequence of technologies, with each step playing a crucial role in efficiently reducing the APIs in the complex matrix to below detection limits within water treatment:

  • Physico-chemical pretreatment (Technology A)
  • Ozonlysis (Technology B)
  • Targeted adsorption (Technology C)

 

 

Our hybrid technology combination delivers the highest selectivity and the lowest energy demand when treating streams containing APIs, in contrast to single-technology approaches such as membranes or electro-oxidation within industrial water treatment processes.

 

our advantages
GENERAL
APPLICABILITY

for API-containing streams

SELECTIVE
REMOVAL

of multiple APIs (99.99999 %)

REDUCED
COSTS

compared to transport & incineration

BROMATE FREE
AOX FREE

Avoiding formation of bromates and removal of halogenated organic compounds (AOX)

INCREASED
EFFICIENCY

due to synergy between different technologies

get in touch

   

Something about cookies...

This website uses only functional cookies, such as a PHPSESSID cookie to create a unique session, and a cookie that remembers that you have already seen this cookie banner so it only appears once. These cookies are necessary for the website to function properly and therefore cannot be disabled. According to European regulations, we are required to inform you about this.

I understand and accept these cookies